| 5/8/2021 |
Bunge Announces Pricing of Senior Notes Offering | Business Wire |
Business Wire |
... be made only by means of the prospectus supplement and the accompanying prospectus related to the offering. Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained at Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected] , Citigroup Global Markets Inc. toll-free at 1-800-831-9146, J.P. Morgan Securities LLC collect ... |
| 5/8/2021 |
Bunge Announces Pricing of Senior Notes Offering |
itbusinessnet.com |
... be made only by means of the prospectus supplement and the accompanying prospectus related to the offering. Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained at Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing , Citigroup Global Markets Inc. toll-free at 1-800-831-9146, J.P. Morgan Securities LLC collect at 1-212-834-4533 or ... |
| 5/8/2021 |
JPMorgan Chase & Co. Reiterates “Neutral” Rating for Wolters Kluwer (OTCMKTS:WTKWY) - Ticker Report |
Ticker Report |
... Äúoverweight‚Äù rating on shares of Wolters Kluwer in a research report on Tuesday, March 2nd. Barclays reissued an ‚Äúequal weight‚Äù rating on shares of Wolters Kluwer in a report on Thursday. The Goldman Sachs Group raised Wolters Kluwer from a ‚Äúsell‚Äù rating to a ‚Äúneutral‚Äù rating in a report on Monday, March 8th. Zacks Investment Research lowered Wolters Kluwer from a ‚Äúhold‚Äù rating to a ... |
| 5/8/2021 |
Credit Suisse Group Reiterates Outperform Rating for Wolters Kluwer (OTCMKTS:WTKWY) |
baseballnewssource.com |
... A number of other equities analysts have also recently issued reports on the company. Morgan Stanley restated an “overweight” rating on shares of Wolters Kluwer in a report on Tuesday, March 2nd. The Goldman Sachs Group upgraded Wolters Kluwer from a “sell” rating to a “neutral” rating in a report on Monday, March 8th. Berenberg Bank restated a “hold” rating on shares of Wolters Kluwer in ... |
| 5/8/2021 |
Wolters Kluwer (OTCMKTS:WTKWY) Stock Rating Reaffirmed by Barclays |
slatersentinel.com |
... a “sell” rating in a research note on Thursday, April 8th. Morgan Stanley restated an “overweight” rating on shares of Wolters Kluwer in a research note on Tuesday, March 2nd. Finally, The Goldman Sachs Group upgraded shares of Wolters Kluwer from a “sell” rating to a “neutral” rating in a research note on Monday, March 8th. One investment analyst has rated the stock with a sell ... |
| 5/8/2021 |
Lyft (NASDAQ:LYFT) PT Raised to $80.00 at Citigroup - Watch List News |
watchlistnews.com |
... February 10th. Piper Sandler boosted their target price on shares of Lyft from $61.00 to $88.00 and gave the company an “overweight” rating in a research note on Wednesday, February 10th. Finally, The Goldman Sachs Group boosted their price objective on shares of Lyft from $44.00 to $74.00 and gave the company a “buy” rating in a research report on Wednesday, February 10th. Eight investment analysts have rated ... |
| 5/8/2021 |
CommScope (NASDAQ:COMM) Sets New 12-Month High on Strong Earnings - Stock Observer |
thestockobserver.com |
... of CommScope from $23.00 to $20.00 in a report on Friday, April 9th. Credit Suisse Group upgraded CommScope from a “neutral” rating to an “outperform” rating in a report on Tuesday. The Goldman Sachs Group boosted their target price on CommScope from $21.00 to $24.00 and gave the company a “buy” rating in a research note on Friday. Morgan Stanley raised their price target on CommScope from ... |
| 5/8/2021 |
Editas Medicine (NASDAQ:EDIT) Issues Earnings Results | Daily Political |
Daily Political |
... hundred day simple moving average of $49.24. Editas Medicine has a one year low of $23.51 and a one year high of $99.95. A number of analysts have weighed in on the stock. The Goldman Sachs Group initiated coverage on shares of Editas Medicine in a research note on Thursday, April 22nd. They set a “sell” rating and a $20.00 price objective for the company. JPMorgan Chase & Co. restated ... |
| 5/8/2021 |
Pegasystems (NASDAQ:PEGA) Downgraded by Zacks Investment Research | Daily Political |
Daily Political |
... Thursday, February 25th. Needham & Company LLC upped their price objective on shares of Pegasystems from $169.00 to $180.00 and gave the company a buy rating in a research note on Thursday, April 29th. The Goldman Sachs Group upped their price objective on shares of Pegasystems from $145.00 to $182.00 and gave the company a buy rating in a research note on Thursday, February 25th. Finally, DA Davidson reaffirmed a buy ... |
| 5/8/2021 |
Health Catalyst, Inc. (NASDAQ:HCAT) Expected to Post FY2022 Earnings of ($1.00) Per Share - Watch List News |
watchlistnews.com |
... Äúoverweight‚Äù rating on the stock. Zacks Investment Research lowered shares of Health Catalyst from a ‚Äúhold‚Äù rating to a ‚Äúsell‚Äù rating in a research report on Tuesday, April 27th. Finally, The Goldman Sachs Group upped their price objective on shares of Health Catalyst from $54.00 to $60.00 and gave the company a ‚Äúbuy‚Äù rating in a research note on Friday. One investment analyst has rated the ... |
| 5/8/2021 |
Oscar Health (NYSE:OSCR) Hits New 52-Week Low at $21.34 - Watch List News |
watchlistnews.com |
... stock. Bank of America assumed coverage on shares of Oscar Health in a report on Monday, March 29th. They issued a “buy” rating and a $39.00 price target on the stock. Finally, The Goldman Sachs Group assumed coverage on shares of Oscar Health in a report on Monday, March 29th. They issued a “buy” rating and a $44.00 price target on the stock. One research analyst has rated ... |
| 5/8/2021 |
Bunge Announces Pricing of Senior Notes Offering |
itbusinessnet.com |
... be made only by means of the prospectus supplement and the accompanying prospectus related to the offering. Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained at Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing , Citigroup Global Markets Inc. toll-free at 1-800-831-9146, J.P. Morgan Securities LLC collect at 1-212-834-4533 or ... |
| 5/8/2021 |
ACADIA Pharmaceuticals (NASDAQ:ACAD) Rating Reiterated by Mizuho | Daily Political |
Daily Political |
... the stock in a report on Tuesday, March 9th. Raymond James cut ACADIA Pharmaceuticals from an “outperform” rating to a “market perform” rating in a research note on Monday, April 5th. The Goldman Sachs Group reissued a “neutral” rating and issued a $25.00 price target (down from $73.00) on shares of ACADIA Pharmaceuticals in a research report on Tuesday, April 13th. Canaccord Genuity reaffirmed a “hold” ... |
| 5/8/2021 |
Oscar Health (NYSE:OSCR) Reaches New 52-Week Low at $21.34 - Ticker Report |
Ticker Report |
... the stock. Cowen began coverage on shares of Oscar Health in a research report on Monday, March 29th. They set a “market perform” rating and a $29.00 price objective on the stock. The Goldman Sachs Group began coverage on shares of Oscar Health in a research report on Monday, March 29th. They set a “buy” rating and a $44.00 price objective on the stock. Finally, Wells Fargo & Company ... |
| 5/8/2021 |
Bunge Announces Pricing of Senior Notes Offering | Financial Buzz |
financialbuzz.com |
... be made only by means of the prospectus supplement and the accompanying prospectus related to the offering. Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained at Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected] , Citigroup Global Markets Inc. toll-free at 1-800-831-9146, J.P. Morgan Securities LLC collect ... |
| 5/8/2021 |
Bunge Announces Pricing of Senior Notes Offering |
Yahoo News |
... be made only by means of the prospectus supplement and the accompanying prospectus related to the offering. Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained at Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected] , Citigroup Global Markets Inc. toll-free at 1-800-831-9146, J.P. Morgan Securities LLC collect ... |
| 5/8/2021 |
Robert De Niro among celebs shilling WELL Health-Safety Seal |
nypost.com |
... a real-estate endorsement that is supposed to provide a COVID pandemic-weary public peace of mind.The International WELL Building Institute, the company behind the effort — founded by a former partner at Goldman Sachs — has also engaged Lady Gaga, Jennifer Lopez and Venus Williams in its minute-long ad spot. The commercial includes nine mentions of “safety” or some variation on the word.The pitch appears ... |
| 5/8/2021 |
Robert De Niro among celebs shilling WELL Health-Safety Seal |
talesbuzz.com |
... a real-estate endorsement that is supposed to provide a COVID pandemic-weary public peace of mind.The International WELL Building Institute, the company behind the effort — founded by a former partner at Goldman Sachs — has also engaged Lady Gaga, Jennifer Lopez and Venus Williams in its minute-long ad spot. The commercial includes nine mentions of “safety” or some variation on the word.The pitch appears ... |
| 5/7/2021 |
Alignment Healthcare (NASDAQ:ALHC) Trading Down 6.5% |
baseballnewssource.com |
... during mid-day trading, a decline of 98% from the average daily volume of 553,203 shares. The stock had previously closed at $26.89.A number of analysts have issued reports on ALHC shares. The Goldman Sachs Group started coverage on Alignment Healthcare in a research report on Monday, April 26th. They issued a “neutral” rating and a $25.00 target price on the stock. William Blair assumed coverage on shares ... |
| 5/7/2021 |
Cigna Corporation (CI) Q1 2021 Earnings Call Transcript |
alphastreet.com |
... NYSE: CI) Q1 2021 earnings call dated May. 07, 2021 Alexis Jones — Investor Relations Lead Principal David Cordani — President and Chief Executive Officer Brian Evanko — Chief Financial Officer Robert Jones — Goldman Sachs — Analyst Ralph Giacobbe — Citigroup — Analyst Justin Lake — Wolfe Research — Analyst George Hill — Deutsche Bank — Analyst A.J. Rice — Credit Suisse — Analyst Kevin Fischbeck — Bank of ... |